Veracyte, Inc.
Veracyte Announces Third Quarter 2026 Financial Results
Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth
Company newsroom
NASDAQ:VCYT
1 releases
Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth